PMC:7346000 / 2480-2701 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PD-FMA-UBERON

    {"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T1","span":{"begin":13,"end":17},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"fma_id","subj":"T1","obj":"http://purl.org/sig/ont/fma/fma7195"}],"text":"h structural lung damage who receive systemic corticosteroids for their underlying condition, such as patients with chronic obstructive pulmonary diseases (COPD) [2].\nRecently, it has been reported that a relatively high "}

    LitCovid-PD-UBERON

    {"project":"LitCovid-PD-UBERON","denotations":[{"id":"T1","span":{"begin":13,"end":17},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"uberon_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/UBERON_0002048"}],"text":"h structural lung damage who receive systemic corticosteroids for their underlying condition, such as patients with chronic obstructive pulmonary diseases (COPD) [2].\nRecently, it has been reported that a relatively high "}

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"66","span":{"begin":102,"end":110},"obj":"Species"},{"id":"79","span":{"begin":13,"end":24},"obj":"Disease"},{"id":"80","span":{"begin":116,"end":154},"obj":"Disease"},{"id":"81","span":{"begin":156,"end":160},"obj":"Disease"}],"attributes":[{"id":"A66","pred":"tao:has_database_id","subj":"66","obj":"Tax:9606"},{"id":"A79","pred":"tao:has_database_id","subj":"79","obj":"MESH:D008171"},{"id":"A80","pred":"tao:has_database_id","subj":"80","obj":"MESH:D029424"},{"id":"A81","pred":"tao:has_database_id","subj":"81","obj":"MESH:D029424"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"h structural lung damage who receive systemic corticosteroids for their underlying condition, such as patients with chronic obstructive pulmonary diseases (COPD) [2].\nRecently, it has been reported that a relatively high "}

    LitCovid-PD-MONDO

    {"project":"LitCovid-PD-MONDO","denotations":[{"id":"T33","span":{"begin":116,"end":154},"obj":"Disease"},{"id":"T34","span":{"begin":136,"end":154},"obj":"Disease"},{"id":"T35","span":{"begin":156,"end":160},"obj":"Disease"}],"attributes":[{"id":"A33","pred":"mondo_id","subj":"T33","obj":"http://purl.obolibrary.org/obo/MONDO_0005002"},{"id":"A34","pred":"mondo_id","subj":"T34","obj":"http://purl.obolibrary.org/obo/MONDO_0005275"},{"id":"A35","pred":"mondo_id","subj":"T35","obj":"http://purl.obolibrary.org/obo/MONDO_0005002"}],"text":"h structural lung damage who receive systemic corticosteroids for their underlying condition, such as patients with chronic obstructive pulmonary diseases (COPD) [2].\nRecently, it has been reported that a relatively high "}

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T13","span":{"begin":13,"end":17},"obj":"http://purl.obolibrary.org/obo/UBERON_0002048"},{"id":"T14","span":{"begin":13,"end":17},"obj":"http://www.ebi.ac.uk/efo/EFO_0000934"},{"id":"T15","span":{"begin":180,"end":183},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"},{"id":"T16","span":{"begin":203,"end":204},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"h structural lung damage who receive systemic corticosteroids for their underlying condition, such as patients with chronic obstructive pulmonary diseases (COPD) [2].\nRecently, it has been reported that a relatively high "}

    LitCovid-PD-CHEBI

    {"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T15","span":{"begin":46,"end":61},"obj":"Chemical"}],"attributes":[{"id":"A15","pred":"chebi_id","subj":"T15","obj":"http://purl.obolibrary.org/obo/CHEBI_50858"}],"text":"h structural lung damage who receive systemic corticosteroids for their underlying condition, such as patients with chronic obstructive pulmonary diseases (COPD) [2].\nRecently, it has been reported that a relatively high "}

    LitCovid-PD-HP

    {"project":"LitCovid-PD-HP","denotations":[{"id":"T8","span":{"begin":116,"end":154},"obj":"Phenotype"},{"id":"T9","span":{"begin":156,"end":160},"obj":"Phenotype"}],"attributes":[{"id":"A8","pred":"hp_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/HP_0006510"},{"id":"A9","pred":"hp_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/HP_0006510"}],"text":"h structural lung damage who receive systemic corticosteroids for their underlying condition, such as patients with chronic obstructive pulmonary diseases (COPD) [2].\nRecently, it has been reported that a relatively high "}

    2_test

    {"project":"2_test","denotations":[{"id":"32599813-25354514-60095061","span":{"begin":163,"end":164},"obj":"25354514"}],"text":"h structural lung damage who receive systemic corticosteroids for their underlying condition, such as patients with chronic obstructive pulmonary diseases (COPD) [2].\nRecently, it has been reported that a relatively high "}